Get notified when TCRX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTScan Therapeutics VP of Finance resigns; CFO assumes accounting officer duties
Filed April 2, 2026 · Period ending March 31, 2026 · ~1 min read
Key Changes
-
medium
Leiden Dworak resigned as VP of Finance and principal accounting officer effective April 10, 2026, with no reported disagreements on operations or policies.
Item 5.02 verify on EDGAR → -
medium
CFO Jason Amello appointed to also serve as principal accounting officer starting April 10, with no additional compensation for the expanded role.
Item 5.02 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.
Partner
Trade TCRX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify